Treating Irritable Bowel Syndrome with a Food Elimination Diet Followed by Food Challenge and Probiotics

Journal of the American College of Nutrition

Volumn 25, Issue 6, 2006, Pages 514-522

  Drisko, Jeanne ^a   Bischoff, Bette ^a   Hall, Matthew ^b   McCallum, Richard ^c  

^a School of Veterinary Medicine   (United States)

^b Public Health and Preventive Medicine   (United States)

^c UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; PLACEBO; PROBIOTIC AGENT;

ADULT; AGED; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CLINICAL ARTICLE; DIET RESTRICTION; FECES ANALYSIS; FEMALE; FOLLOW UP; HUMAN; HYDROGEN BREATH TEST; IMMUNE SYSTEM; IMMUNOGLOBULIN BLOOD LEVEL; INFLAMMATION; INTESTINE FLORA; IRRITABLE COLON; MACROMOLECULE; MALE; MEDIATOR RELEASE; NUTRITIONAL INTOLERANCE; PILOT STUDY; QUALITY OF LIFE; QUESTIONNAIRE; SYMPTOMATOLOGY; TREATMENT RESPONSE; UPREGULATION;

ADULT; AGED; AGED, 80 AND OVER; BREATH TESTS; COHORT STUDIES; DIARRHEA; FECES; FEMALE; FOLLOW-UP STUDIES; FOOD HYPERSENSITIVITY; HUMANS; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IRRITABLE BOWEL SYNDROME; MALE; MIDDLE AGED; PILOT PROJECTS; PROBIOTICS; PROSPECTIVE STUDIES; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 33846648646     PISSN: 07315724     EISSN: 15411087     Source Type: Journal    
DOI: 10.1080/07315724.2006.10719567     Document Type: Article

References (61)

1. Mertz HR: Irritable bowel syndrome. N Engl J Med 349: 2136-2146, 2003.
2. Horwitz BJ, Fisher RS: The irritable bowel syndrome. N Engl J Med 344: 1846-1850, 2001.
3. Maxwell PR, Mendall MA, Kumar D: Irritable bowel syndrome. Lancet 350: 1691-1695, 1997.
4. Everhart JE, Renault PF: Irritable Bowel Syndrome in office-based practice in the United States. Gastroenterology 100: 998-1005, 1991.
5. Drossman DA, Corazziari E, Talley NJ, Thompson WG, Whitehead WE (eds) –Rome II. The Functional Gastrointestinal Disorders,— 2nd ed. Lawrence, KS: Allen Press Inc, 2000.
6. Talley NJ, Gabriel SE, Harmsen WS, Zinsmeister AR, Evans RW: Alimentary Tract: medical costs in community subjects with irritable bowel syndrome. Gastroenterology 109: 1736-1741, 1995.
7. Levy RL, Von Korff M, Whitehead WE, Stang P, Saunders K, Jhingran P, Barghout V, Feld AD: Costs of care for irritable bowel syndrome patients in a health maintenance organization. Am J Gastroenterol 96: 3122-3129, 2001.
8. Dunphy RC, Verne GN: Drug treatment options for irritable bowel syndrome-managing for success. Drugs Aging 18: 201-211, 2001.
9. Villanueva A, Dominguez-Munoz JE, Mearin F: Update in the therapeutic management of irritable bowel syndrome. Dig Dis 19: 244-250, 2001.
10. Mayer L: Mucosal immunity and gastrointestinal antigen processing. J Pediatr Gastroenterol Nutr 30: S4-S12, 2000.
11. Collins SM: A case for an immunological basis for irritable bowel syndrome. Gastroenterology 122: 2078-2080, 2002.
12. Chadwick VS, Chen W, Shu D, Paulus B, Bethwaite P, Tie A, Wilson I: Activation of the mucosal immune system in irritable bowel syndrome. Gastroenterology 122: 1778-1783, 2002.
13. Gonsalkorale WM, Perrey C, Pravica V, Whorwell PJ, Hutchinson IV: Interleukin 10 genotypes in irritable bowel syndrome: evidence for an inflammatory component? Gut. 52: 91-93, 2003.
14. King TS, Elia M, Hunter JO: Abnormal colonic fermentation in irritable bowel syndrome. Lancet 352: 1187-1189, 1998.
15. Ciprandi G, Canonica GW: Incidence of digestive diseases in patients with adverse reactions to foods. Ann Allergy 61: 334-336, 1998.
16. De Simone C, Famularo G, Salvadori BB, Moretti S, Marcellini S, Trinchieri V, Santini G: Treatment of irritable bowel syndrome (IBS) with the newer probiotic vs #3: a multicenter trial. Am J Clin Nutr 73(Suppl): 491S, 2001.
17. Nobaek S, Johansson ML, Molin G, Ahrne S, Jeppsson B: Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome. Am J Gastroenterol 95: 1231-1238, 2000.
18. Petitpierre M, Gumowski P, Girard JP: Irritable bowel syndrome and hypersensitivity to food. Ann Allergy 54: 538-540, 1985.
19. Balsari A, Ceccarelli A, Dubini F, Fesce E, Poli G: The fecal microbial population in the irritable bowel syndrome. Microbiologica 5: 185-194, 1982.
20. O'Mahony L, McCarthy J, Kelly P, Hurley G, Luo F, Chen K, O'Sullivan GC, Kiely B, Collins JK, Shanahan F, Quigley EM: Lactobacillus and Bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology 128: 783-785, 2005.
21. Walker WA: Role of nutrients and bacterial colonization in the development of intestinal host defense. J Pediatr Gastroenterol Nutr 30: S2-S7, 2000.
22. Crowe SE, Perdue MH: Gastrointestinal food hypersensitivity. Basic mechanisms of pathophysiology. Gastroenterol Nutr 103: 1075-1095, 1992.
23. Crowell MD: The role of serotonin in the pathophysiology ofirritable bowel syndrome. Am J Managed Care 7: S252-S260, 2001.
24. Gershon MD: Review Article: Roles played by 5-hydroxytryptamine in the physiology of the bowel. Aliment Pharmacol Ther 13(Suppl): 15-30, 1999.
25. Joneja JMV, Carmona-Silva C: Outcome of a histamine-restricted diet based on chart audit. J Nutritional Environ Med 11: 249-262, 2001.
26. Gui XY: Mast cells: A possible link between psychological stress, enteric infection, food allergy, and gut hypersensitivity in the irritable bowel syndrome. J Gastroenterol Hepatol 13: 980-989, 1998.
27. Houghton LA, Atkinson W, Whitaker RP, Whorwell PJ, Rimmer MJ: Increased platelet depleted plasma 5-hydroxytryptamine concentration following meal ingestion in symptomatic female subjects with diarrhoea predominant irritable bowel syndrome. Gut 52: 663-670, 2003.
28. Miwa J, Echizen H, Matsuedo K, Umeda N: Patients with constipation-predominant irritable bowel syndrome (IBS) may have elevated serotonin concentrations in colonic mucosa as compared to diarrhea-predominant patients and subjects with normal bowel habits. Digestion 63: 188-194, 2001.
29. Talley NJ: Serotoninergic neuroenteric modulators. Lancet 358: 2061-2068, 2001.
30. Barau E, Dupont C: Modifications of intestinal permeability during food provocation procedures in pediatric irritable bowel syndrome. J Ped Gastroenterol 11: 72-77, 1990.
31. Fell PJ, Soulsby S, Brostoff J: Cellular responses to food in irritable bowel syndrome-an investigation of the ALCAT test. J Nutr Med 2: 143-149, 1991.
32. Dixon HS: Treatment of delayed food allergy based on specific immunoglobulin G RAST testing. Otolaryngology-Head and Neck Surgery 123(1-Part 1): 48-54, 2000.
33. Atkinson W, Sheldon TA, Shaath N, Whorwell PJ: Food elimination based on IgG antibodies in irritable bowel syndrome: a randomised controlled trial. Gut 53: 1459-1464, 2004.
34. Parker TJ, Naylor SJ, Riordan AM, Hunter JO: Management of patients with food intolerance in irritable bowel syndrome: the development and use of an exclusion diet. J Hum Nutr Diet 8: 159-166, 1995.
35. Nanda R, James R, Smith H, Dudley CRK, Jewell DP: Food intolerance and the irritable bowel syndrome. Gut 30: 1099-1104, 1989.
36. Sampson HA, Burks AW: Mechanisms of food allergy. Annual Rev Nutr 16: 161-177, 1996.
37. Bourlioux P, Koletzko B, Guarner F, Braesco V: The intestine and its microflora are partners for the protection of the host: Report on the Danone Symposium –The Intelligent Intestine,— held in Paris, June 14, 2002. Am J Clin Nutr 78: 675-683, 2003.
38. Halpern GM, Prindiville T, Blankenburg M, Hsia T, Gershwin ME: Treatment of irritable bowel syndrome with lacteol fort: a randomized, double-blind, cross-over trial. Am J Gastroenterol 91: 1579-1585, 1996.
39. Hamilton-Miller JMT: Probiotics in the management of irritable bowel syndrome: a review of clinical trials. Microbial Ecology Health Dis 13: 212-216, 2001.
40. Mai V, Morris G: Colonic bacterial flora: Changing understandings in the molecular age. J Nutr 134: 459-464, 2004.
41. Majamaa H, Isolauri E: Probiotics: a novel approach in the management of food allergy. J Allergy Clin Immunol 99: 179-185, 1997.
42. Niedzielin K, Kordecki H, Kosik R: New possibility in the treatment of irritable bowel syndrome: probiotics as a modification of the microflora of the colon. Gastroenterology 114: A402, 1998.
43. Pearce L, Bampton PA, Borody TJ, Shortis NP: Modification of the colonic microflora using probiotics: The way forward? Gut 41: A63, 1997.
44. Lin HC: Small intestinal bacterial overgrowth: A framework for understanding the irritable bowel syndrome. JAMA 292: 852-858, 2004.
45. Patrick DL, Drossman DA, Frederick IO, DiCesare J, Puder KL: Quality of life in persons with irritable bowel syndrome: development and validation of a new measure. Dig Dis Sci 43: 400-411, 1998.
46. Drossman DA, Creed FH, Fava GA, Olden KW, Patrick DL, Toner BB, Whitehead WE: Psychosocial aspects of the functional gastrointestinal disorders. Gastroenterol Int 8: 47-90, 1995.
47. King HC: Exploring the maze of adverse reactions to foods. Ear Nose Throat J 73: 237-241, 1994.
48. Gordon BR: Approaches to testing for food and chemical sensitivities. Otolryngol Clin N Am 36: 917-940, 2003.
49. Baker SM, McDonnell M, Truss CV: Double Blind Placebo Diet Controlled Crossover Study of IgG Food ELISA. Presented at American Academy of Environmental Medicine Advanced Seminar, Virginia Beach, VA. October 1994.
50. Sampson HA: Food allergy. Part 2: Diagnosis and management. J Allergy Clin Immunol 103: 981-989, 1999.
51. Sicherer SH: Clinical implications of cross-reactive food allergens. J Allergy Clin Immunol 108: 881-890, 2001.
52. Sicherer SH: Food allergy: When and how to perform oral food challenges. Pediatr Allergy Immunol 10: 226-234, 1999.
53. American Gastroenterological Association Medical Position Statement: Guidelines for the evaluation of food allergies. Gastroenterology 120: 1023-1025, 2001.
54. Casimer GJ, Duchateau J, Gossart B, Cuvelier P, Vandaele F, Vis HL: Atopic dermatitis: role of food and house dust mite allergens. Pediatrics 92: 252-256, 1993.
55. Sampson HA, Sicherer SH, Birnbaum AH: AGA technical review on the evaluation of food allergy in gastrointestinal disorders. Gastroenterology 120: 1026-1040, 2001.
56. Miller SB: IgG Food Allergy Testing by ELISA/EIA-what do they really tell us? Townsend Letter for Doctors & Patients [January] 62-65, 1998.
57. Vanderhoof JA, Young RJ: Use of probiotics in childhood gastrointestinal disorders. J Pediatr Gastroenterol Nutr 27: 323-332, 1998.
58. Marteau PR, de Vrese M, Cellier CJ, Schrezenmeir J: Protection from gastrointestinal diseases with the use of probiotics. Am J Clin Nutr 73(Suppl): 430S-436S, 2001.
59. Wong E, Guyatt GH, Cook DJ, Griffith LE, Irvine EJ: Development of a questionnaire to measure quality of life in patients with irritable bowel syndrome. Eur J Surg Suppl 583: 50-56, 1998.
60. Schmulson M, Lee OY, Chang L, Naliboff B, Mayer EA. Symptom differences in moderate to severe IBS patients based on predominant bowel habit. Am J Gastroenterol 94: 2929-2935, 1999.
61. Sperber AD, Carmel S, Atzmon Y: Use of the Functional Bowel Disorder Severity Index (FBDSI) in a study of patients with the irritable bowel syndrome and fibromyalgia. Am J Gastroenterol 95: 995-998, 2000.